BioCryst Pharmaceuticals, Inc.
Balance Sheet
| Line Item | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $50.3M | $22.1M | $28.9M | $54.5M | $21.2M | $20.9M | $16.4M | $13.6M |
| Accounts Receivable | $6.1M | $8.8M | $6.2M | $3.8M | $2.1M | $4.6M | $5.8M | $30.2M |
| Inventory | — | $500.0K | $1.6M | $683.0K | — | — | $263.0K | $898.0K |
| Total Current Assets | $125.4M | $67.0M | $63.8M | $89.3M | $42.1M | $42.0M | $52.9M | $87.4M |
| Property, Plant & Equipment | $9.5M | $9.9M | $5.1M | $207.0K | $306.0K | $583.0K | $1.1M | $1.9M |
| Goodwill | — | — | — | — | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | — | — | — | — | — | — | — | — |
| Total Assets | $178.3M | $89.8M | $122.4M | $136.9M | $48.9M | $57.4M | $82.2M | $109.4M |
| Liabilities | ||||||||
| Accounts Payable | $6.3M | $4.3M | $9.3M | $2.8M | $4.2M | $4.0M | $2.5M | $8.2M |
| Total Current Liabilities | $74.8M | $54.4M | $62.3M | $57.3M | $15.3M | $17.2M | $26.3M | $28.0M |
| Long-Term Debt | $23.0M | $23.0M | — | — | — | — | — | — |
| Total Liabilities | $94.5M | $88.3M | $74.6M | $61.2M | $50.0M | $57.9M | $67.4M | $43.9M |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-631.8M | $-566.1M | $-510.9M | $-467.9M | $-422.7M | $-392.6M | $-353.5M | $-296.6M |
| Total Stockholders' Equity | $83.8M | $1.6M | $47.7M | $75.6M | $-1.1M | $-454.0K | $14.8M | $65.5M |